RxDoctor Payments Data

Lorenzo Corpus, MD

Family Medicine · Jacksonville, FLNPI 1689641110

Payments from drug & device makers

$1,239in general payments, 2019–2025

Across 32 payments — averaging $38.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$308
  • Abbott$194
  • Boehringer Ingelheim$149
  • Abiomed$129
  • Dexcom, Inc.$102
  • Amgen$59
  • plus $299 from 9 others

What the payments were for

  • Food & beverage$1,239100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,239 in reported general payments places this provider in the 65th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$40,748
Medicare patients
101
Services billed
518

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate48$45,430
JardianceEmpagliflozin37$39,491
OzempicSemaglutide33$30,704
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$12,897
Combivent RespimatIpratropium/Albuterol Sulfate19$11,940
FarxigaDapagliflozin Propanediol11$11,126
Bydureon BciseExenatide Microspheres11$9,128
BrilintaTicagrelor11$7,713
SymbicortBudesonide/Formoterol Fumarate12$3,573
Ventolin HfaAlbuterol Sulfate39$2,169
Albuterol Sulfate HfaAlbuterol Sulfate73$2,155
Fluticasone-SalmeterolFluticasone Propion/Salmeterol19$1,983
Atorvastatin Calcium177$1,477
Omeprazole84$1,467
Pregabalin27$1,416

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Combivent Respimat$149$51,43256 claims
Novo NordiskOzempic$49$30,70433 claims
AstraZenecaFarxiga, Brilinta, Symbicort$44$22,41234 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →